These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

309 related articles for article (PubMed ID: 35139474)

  • 1. Pinpoint modification strategy for stabilization of single guide RNA.
    Takeuchi S; Yamamoto M; Matsumoto S; Kenjo E; Karashima M; Ikeda Y
    J Chromatogr B Analyt Technol Biomed Life Sci; 2022 Mar; 1192():123149. PubMed ID: 35139474
    [TBL] [Abstract][Full Text] [Related]  

  • 2. HIV-1 Employs Multiple Mechanisms To Resist Cas9/Single Guide RNA Targeting the Viral Primer Binding Site.
    Wang Z; Wang W; Cui YC; Pan Q; Zhu W; Gendron P; Guo F; Cen S; Witcher M; Liang C
    J Virol; 2018 Oct; 92(20):. PubMed ID: 30068653
    [TBL] [Abstract][Full Text] [Related]  

  • 3. "Split-and-Click" sgRNA.
    Taemaitree L; Shivalingam A; El-Sagheer AH; Brown T
    Methods Mol Biol; 2021; 2162():61-78. PubMed ID: 32926378
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Minimal 2'-O-methyl phosphorothioate linkage modification pattern of synthetic guide RNAs for increased stability and efficient CRISPR-Cas9 gene editing avoiding cellular toxicity.
    Basila M; Kelley ML; Smith AVB
    PLoS One; 2017; 12(11):e0188593. PubMed ID: 29176845
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Conjugation and Evaluation of Triazole-Linked Single Guide RNA for CRISPR-Cas9 Gene Editing.
    He K; Chou ET; Begay S; Anderson EM; van Brabant Smith A
    Chembiochem; 2016 Oct; 17(19):1809-1812. PubMed ID: 27441384
    [TBL] [Abstract][Full Text] [Related]  

  • 6. sgRNA Sequence Motifs Blocking Efficient CRISPR/Cas9-Mediated Gene Editing.
    Graf R; Li X; Chu VT; Rajewsky K
    Cell Rep; 2019 Jan; 26(5):1098-1103.e3. PubMed ID: 30699341
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Generalizable sgRNA design for improved CRISPR/Cas9 editing efficiency.
    Hiranniramol K; Chen Y; Liu W; Wang X
    Bioinformatics; 2020 May; 36(9):2684-2689. PubMed ID: 31971562
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Optimizing sgRNA length to improve target specificity and efficiency for the GGTA1 gene using the CRISPR/Cas9 gene editing system.
    Matson AW; Hosny N; Swanson ZA; Hering BJ; Burlak C
    PLoS One; 2019; 14(12):e0226107. PubMed ID: 31821359
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Optimized paired-sgRNA/Cas9 cloning and expression cassette triggers high-efficiency multiplex genome editing in kiwifruit.
    Wang Z; Wang S; Li D; Zhang Q; Li L; Zhong C; Liu Y; Huang H
    Plant Biotechnol J; 2018 Aug; 16(8):1424-1433. PubMed ID: 29331077
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Molecular basis for the PAM expansion and fidelity enhancement of an evolved Cas9 nuclease.
    Chen W; Zhang H; Zhang Y; Wang Y; Gan J; Ji Q
    PLoS Biol; 2019 Oct; 17(10):e3000496. PubMed ID: 31603896
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Enhancement of single guide RNA transcription for efficient CRISPR/Cas-based genomic engineering.
    Ui-Tei K; Maruyama S; Nakano Y
    Genome; 2017 Jun; 60(6):537-545. PubMed ID: 28177825
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Coordinated Actions of Cas9 HNH and RuvC Nuclease Domains Are Regulated by the Bridge Helix and the Target DNA Sequence.
    Babu K; Kathiresan V; Kumari P; Newsom S; Parameshwaran HP; Chen X; Liu J; Qin PZ; Rajan R
    Biochemistry; 2021 Dec; 60(49):3783-3800. PubMed ID: 34757726
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Gene Editing in B-Lymphoma Cell Lines Using CRISPR/Cas9 Technology.
    Bai B; Myklebust JH; Wälchli S
    Methods Mol Biol; 2020; 2115():445-454. PubMed ID: 32006416
    [TBL] [Abstract][Full Text] [Related]  

  • 14. CNN-XG: A Hybrid Framework for sgRNA On-Target Prediction.
    Li B; Ai D; Liu X
    Biomolecules; 2022 Mar; 12(3):. PubMed ID: 35327601
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Fast and Efficient CRISPR/Cas9 Genome Editing In Vivo Enabled by Bioreducible Lipid and Messenger RNA Nanoparticles.
    Liu J; Chang J; Jiang Y; Meng X; Sun T; Mao L; Xu Q; Wang M
    Adv Mater; 2019 Aug; 31(33):e1902575. PubMed ID: 31215123
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Disabling Cas9 by an anti-CRISPR DNA mimic.
    Shin J; Jiang F; Liu JJ; Bray NL; Rauch BJ; Baik SH; Nogales E; Bondy-Denomy J; Corn JE; Doudna JA
    Sci Adv; 2017 Jul; 3(7):e1701620. PubMed ID: 28706995
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Review of CRISPR/Cas9 sgRNA Design Tools.
    Cui Y; Xu J; Cheng M; Liao X; Peng S
    Interdiscip Sci; 2018 Jun; 10(2):455-465. PubMed ID: 29644494
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Kinetics of the CRISPR-Cas9 effector complex assembly and the role of 3'-terminal segment of guide RNA.
    Mekler V; Minakhin L; Semenova E; Kuznedelov K; Severinov K
    Nucleic Acids Res; 2016 Apr; 44(6):2837-45. PubMed ID: 26945042
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Application of the CRISPR/Cas system for genome editing in microalgae.
    Zhang YT; Jiang JY; Shi TQ; Sun XM; Zhao QY; Huang H; Ren LJ
    Appl Microbiol Biotechnol; 2019 Apr; 103(8):3239-3248. PubMed ID: 30877356
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Versatile 3' Functionalization of CRISPR Single Guide RNA.
    Palumbo CM; Gutierrez-Bujari JM; O'Geen H; Segal DJ; Beal PA
    Chembiochem; 2020 Jun; 21(11):1633-1640. PubMed ID: 31943634
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.